000			03481cam a2200397Mi 4500
999			_c96738 _d96738 _x1
001			96738
003			ES-MaUEC
005			20230102112808.0
006			m o d
007			cr nn||||mamaa
008			171027s2017 gw a ob 000 0 eng d
020			_a3319653199
020			_a9783319653198
020			_z3319653180
020			_z9783319653181
040			_aUPM _beng _epn _cUPM _dN$T _dGW5XE _dDKU _dEBLCP _dYDX _dOCLCO _dOCLCQ _dOCLCF _dCOO _dOCLCQ _dIOG _dUAB _dMERER _dOCL _dES-MaUEC _bspa
050		4	_aQH588.S83 _b2017 EB
245	0	0	_aHaploidentical Stem Cell Transplantation : _ban Emerging Treatment Modality _cedited by Taner Demirer.
264		1	_aCham, Switzerland _bSpringer International Publishing : _bImprint : _bHumana Press _c2017
300			_a1 recurso en línea (XV, 199 páginas) _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
490	0		_aStem Cell Biology and Regenerative Medicine _x2196-8985
500			_a
504			_aIncluye referencias bibliográficas
505	0		_a1. General Indications and Logic for Haploidentical SCT -- 2. Donor Selection and Cell Dose in Haploidentical SCT -- 3. Graft Failure and Rejection in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 5. An Overview of the Prophylaxis and Treatment of GVHD in Haploidentical STC -- 6. Prevention and Treatment of Infectious Complications in Haploidentical SCT -- 7. Graft versus Leukemia (GVL), Graft versus Lymphoma Effect in Haploidentical SCT -- 8. Outcome of Haploidentical SCT in Patients with Acute Leukemia -- 9. Outcome of Haploidentical SCT in Patients with Lymphoma -- 10. Applications of Haploidentical SCT in Patients with Non-malignant Diseases -- 11. Applications of Haploidentical SCT in Pediatric Patients -- 12. Innovative Approaches in Order to Increase the Success of the Haploidentical SCT. 13. Future Perspectives for Haploidentical SCT.
520	3		_aThis book discusses the aspects of haploidentical transplants and will shed light on the debates and questions on this burgeoning field and timely topic. Donor selection, graft failure, minimal CD34+ cell requirement, and conditioning regimens used for haploidentical transplants will be written by expert authors dealing with this type of transplants. Approximately one third of the books' chapters cover logic and basic aspects; the remaining two thirds of the book discuss clinical aspects, outcomes, and future perspectives, thus providing a comphrensive discussion of the topic. Haploidentical transplantation is extremely timely, rapidly-changing area and increasing its use will decrease the need for time-consuming, expensive, unrelated donor search. Moreover, Haploidentical Stem Cell Transplantation brings a set of clear answers to questions of feasibility, advantages over unrelated transplants, cost effectivity and outcome.
988			_aEBOOK, EBSPRINGER_2017
650		7	_aCélulas madre _2embne _0(OCoLC)fst01132975 _0LocalZ _9160528
700	1		_aDemirer, Taner, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-65319-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI